CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 772 enrolled
Drug / intervention
Warfarindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01996657
NCT01996657N/ACompleted

D-dimer Levels Determined the Intensity of Anticoagulation Therapy to Improve Outcomes in Patients With Mechanical Valve Replacement

Wuhan Asia Heart Hospital·observational·Posted Nov 27, 2013·Updated Jun 26, 2017

In Brief

An observational study evaluating Warfarin for Heart Valve Disease. Completed, enrolled 772 participants across 2 sites.

Detailed Summary

The optimal intensity of oral anticoagulation in China patients undergoing mechanical valve replacements is still controversial due to the different risk profiles of thrombophilia and bleeding in Chinese patients. Elevated D-dimer could reflect a pro-thrombogenic or prothrombotic state, and thus might be used to decide the intensity of oral anticoagulation. This study was to evaluate whether elevated D-dimer levels could help to determine the intensity of oral anticoagulation in patients with mechanical heart valve prostheses.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 27, 2013
Enrollment StartJan 1, 2013
Primary CompletionMay 1, 2016
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.6 years ago

Interventions

Warfarindrug